Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A. (Q39577867)
Jump to navigation
Jump to search
scientific article published on 10 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A. |
scientific article published on 10 March 2011 |
Statements
1 reference
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A. (English)
1 reference
1 reference
Hui-Chuan Yu
1 reference
Chun-Yu Liu
1 reference
Hui-Ju Chen
1 reference
Yi-Ching Chen
1 reference
10 March 2011
1 reference
1 reference
Identifiers
1 reference